Chung-Han Hsieh, PhD, earned an MS in neuroanatomy from Chang-Gung University, Taiwan in 2001; a PhD in neuroscience from Chang-Gung University, Taiwan in 2010; and did post-doctoral training in mitochondrial cell biology at Stanford University. Dr. Hsieh has worked as a senior scientist in CuraX Therapeutics since 2019.

Dr. Hsieh’s research aims to understand the regulatory mechanisms controlling mitochondrial dynamics, identify molecular targets and pharmacodynamic markers for Parkinson’s disease, and explore the clinical utility of a mitochondrial marker for gauging potential treatments.